InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Ashe Andrew D., Autre. Officer active across 1 companies, notably Verve Therapeutics, Inc.. In total, 2 disclosures have been logged. Total volume traded: €227k. The latest transaction was disclosed on 2 December 2021 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
€113,4504,000 shares@ €28.3624100.0% of flow
Common Stock
SEC:0000899243-21-046888·
Ideal exit: 29 Aug 2022 (T+270)
€113,4504,000 shares@ €28.362450.0% of flow
Common Stock
SEC:0000899243-21-046888:0·
Ideal exit: 29 Aug 2022 (T+270)
2 of 2 declarations
About Ashe Andrew D.
Andrew D. Ashe is associated with Verve Therapeutics, Inc. Although his specific role is not detailed, he contributes to the strategic direction of the company. His expertise in the biotechnology field is an asset to Verve Therapeutics.
